Accent Therapeutics, Inc.
Edit

Accent Therapeutics, Inc.

http://www.accenttx.com/
Last activity: 23.01.2024
Categories: GrowthLifeScienceBioTechChemicalDrug
Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer.
Followers
654
Followers
2.27K
Mentions
16
Location: United States, Massachusetts, Lexington
Employees: 11-50
Total raised: $178M
Founded date: 2017

Investors 6

Funding Rounds 3

DateSeriesAmountInvestors
23.01.2024Series C$75M-
24.04.2020Series B$63M-
23.05.2018Series A$40M-

Mentions in press and media 16

DateTitleDescriptionSource
23.01.2024Accent Therapeutics Raises $75M in Series C FundingAccent Therapeutics, a Lexington, MA-based biopharmaceutical company focused on small molecule preci...finsmes.co...
27.02.2023Accent Therapeutics upgrades to Xavo R3 for their small mole...Xavo, a leading provider of Software-as-a-Service for Biopharma R&D announces that Accent Therap...einpresswi...
29.04.2021ALDEYRA THERAPEUTICS, INC. Aldeyra Therapeutics, Inc. : Ann...Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused ...marketscre...
27.04.2021ALDEYRA THERAPEUTICS, INC. Aldeyra Therapeutics, Inc. : Ann...Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused ...marketscre...
01.07.2020June VC Funding: 65 startups raise over $2.2B with agtech, b...It is summer for Boston startups indeed. More than 60 startups raised over $2 billion in venture fun...bizjournal...
24.04.2020Accent Therapeutics Completes $63M Series B FinancingAccent Therapeutics, a Lexington, MA-based biopharmaceutical company developing breakthrough treatme...finsmes.co...
24.04.2020Cancer Therapy Company Accent Therapeutics Raises $63 Millio...Biopharmaceutical company Accent Therapeutics announced it has raised $63 million in Series B fundin...pulse2.com...
23.04.2020Accent Therapeutics Announces $63 Million Series BLEXINGTON, Mass.--(BUSINESS WIRE)--Accent Therapeutics, a biopharmaceutical company developing break...citybizlis...
23.04.2020Accent Therapeutics nabs $63M for RNA cancer pushTwo years ago, Accent Therapeutics got off a $40 million series A to target RNA-modifying proteins i...fiercebiot...
23.04.2020It's not de­vel­op­ing drugs that bind to RNA, or mor­ph­ing...First came the con­cept of epi­ge­net­ics, the study of chem­i­cal mod­i­fi­ca­tions made to the blu...endpts.com...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In